Jun-Hun Pan

Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China

Li Li, Jing Liu, Danping Hu, 2022, BMC Medical Genomics.

Efficacy and Safety of Sintilimab Plus Anlotinib for PD-L1–Positive Recurrent or Metastatic Cervical Cancer: A Multicenter, Single-Arm, Prospective Phase II Trial

Li Li, Chuanben Chen, Meifang Ke, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of Common Cold Patients with the Shi-Cha Capsule: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Escalation Trial

B. Mao, Jing Chang, S. Dong, 2012, Evidence-based complementary and alternative medicine : eCAM.

A Comprehensive Analysis of Prognostic Indicators in Serous Ovarian Cancer Based on Leukocyte Migration and Immune Microenvironment.

Li Li, S. Qiu, Xiaochuan Chen, 2023, Frontiers in bioscience.

CENPK Interacts with SOX6 to Promote Cervical Cancer Stemness and Chemoresistance Through Wnt and P53 Signaling

Li Li, Chuanben Chen, Jing Liu, 2021 .

A Metastatic Cervical Adenocarcinoma Patient Carrying HER2 G292R Achieved Complete Response Upon Pyrotinib Treatment

Li Li, Jing Liu, Feng Wang, 2021, OncoTargets and therapy.